An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology from 2018 to 2020

April 2022 | Volume 21 | Issue 4 | Editorials | 441 | Copyright © April 2022


Published online March 25, 2022

Britney Wilson MBS,a* Mary Sun BSE BA,b* Sumanth Chennareddy BA,b Dedee Murrell MD,c,d** Jenny Murase MDe,f**

aSchool of Medicine, Rutgers New Jersey Medical School, Newark, NJ
bIcahn School of Medicine at Mount Sinai, New York, NY
cThe George Institute of Global Health, Sydney, Australia
dUniversity of New South Wales, Sydney, Australia
eUniversity of California, San Francisco, San Francisco, CA
fPalo Alto Foundation Medical Group, Mountain View, CA
*Co-first authors
**Co-senior authors



(61.88%) of articles were Tier 1B, whereas the majority (59.7%) of articles were Tier 1A in the JDD. Given that the percentage of Tier 1A articles was lowest (5.44%) in SOC journals,3 it is notable that the majority JDD SOC articles were at the intersections of SOC, skin type, and race or ethnicity. The JDD ranked 26 of the 52 journals analyzed for inclusion of SOC literature.

To improve representation of SOC, we recommend that journal editors utilize our criteria to evaluate SOC content and strive for at least 16% SOC content in each issue. In addition, we recommend that the JDD continue to publish SOC special issues, similar to the July 2020 issue. We further encourage this publication to adopt a “skin of color” keyword, which would allow for SOC literature to be more accessible to practitioners. Given skin tone may play an important role in therapeutic efficacy, we believe the JDD has a critical role in providing practitioners with access to information to optimize care and clinical decision making for SOC patients.

DISCLOSURES

The authors have no conflicts of interest to declare.

REFERENCES

1. Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46, (2 Suppl Understanding):S98-106.
2. Battle F, Battle S. Clinical evaluation of safety and efficacy of fractional radiofrequency facial treatment of skin type VI patients. J Drugs Dermatol. 2018;17(11):1169-1172.
3. Wilson BN, Sun M, Ashbaugh AG, et al. Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action. Int J Womens Dermatol. 2021;7(4):391-39.

AUTHOR CORRESPONDENCE

Sumanth Chennareddy BA sumanth.chennareddy@icahn.mssm.edu